Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Circulating Tumor Cell Changes and Efficacy of Neoadjuvant Chemotherapy for Triple-negative Breast Cancer: a Cohort Trial

NCT04059003 is registered in ClinicalTrials.gov with Shengjing Hospital as lead sponsor.

NCT NCT04059003
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04059003 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Circulating Tumor Cell Changes and Efficacy of Neoadjuvant Chemotherapy for Triple-negative Breast Cancer: a Cohort Trial
Lead sponsor
Shengjing Hospital
Phase
Observational
Overall status
Unknown status
Start date
November 1, 2019
Completion date
August 31, 2024
Enrollment
200 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

breast neoplasms